#Sustainability #China #Shanghai #EcoVadis #WuXi AppTec

WuXi AppTec Achieves EcoVadis Gold Medal for Sustainability

In a remarkable feat, WuXi AppTec, a prominent player in the global pharmaceutical CRDMO sector, has been awarded the EcoVadis Gold Medal for the third year in a row. This accolade underscores the company's unwavering commitment to sustainability and responsible business practices. As one of the top 5% of companies evaluated by EcoVadis, WuXi AppTec continues to set a benchmark in sustainability within the pharmaceutical industry.

EcoVadis is widely recognized as a leading sustainability rating agency, which evaluates companies based on 21 sustainability criteria. These criteria are categorized under four key themes: Environment, Labor and Human Rights, Ethics, and Sustainable Procurement. The Gold Medal is a prestigious recognition given only to the top performers in the global business landscape, highlighting WuXi AppTec’s dedication to sustainable operations.

Dr. Steve Yang, Co-CEO of WuXi AppTec and Chairman of the company's Sustainability Committee, expressed pride in this achievement, stating, "We are honored to once again receive the EcoVadis Gold Medal. This recognition reflects the significant progress we have made in implementing sustainability and responsible business practices throughout our entire value chain." Dr. Yang further emphasized the company's commitment to driving the development of the global pharmaceutical sector, asserting that they enable clients to deliver medicines that can change lives.

WuXi AppTec’s holistic approach to sustainability integrates environmentally friendly practices across all operations. The company aligns its sustainability vision with the values of its clients and partners, ensuring that it meets the expectations of a modern pharmaceutical firm. This alignment has also resulted in WuXi AppTec receiving multiple high ratings from other global agencies, including an "AAA" rating from MSCI, an "A List" ranking from CDP for Climate Change, and a spot in the FTSE4Good Index Series.

Furthermore, WuXi AppTec's greenhouse gas emissions reduction targets have been validated by the Science Based Targets initiative (SBTi), marking their progress and dedication to tackling climate change. Participation in the United Nations Global Compact (UNGC) further solidifies the firm’s commitment to global sustainability principles. Additionally, the company collaborates with the Pharmaceutical Supply Chain Initiative (PSCI), reinforcing its role in promoting responsible supply chain practices across the industry.

Commitment to Innovation

As an enabler of innovation in the pharmaceutical and life sciences sectors, WuXi AppTec provides comprehensive solutions that advance healthcare innovation. Their CRDMO platform allows for integrated services ranging from research and development to manufacturing. This unique approach enhances WuXi AppTec’s ability to partner with organizations in over 30 countries, supporting the global effort to bring groundbreaking treatments to market.

The company’s vision, that every drug can be developed and every disease treated, guides its strategic direction. WuXi AppTec's commitment to sustainability is not merely a business strategy; it is an integral part of how the company operates, ensuring that the industry can provide ethical and effective healthcare solutions for the future.

In summary, WuXi AppTec’s achievement of the EcoVadis Gold Medal for the third consecutive year stands as a testament to its ongoing efforts within the realm of sustainability. The recognition not only highlights the company’s accomplishments but also paves the way for future endeavors to enhance sustainable practices in the pharmaceutical industry. Through strategic initiatives and collaboration, WuXi AppTec remains at the forefront of sustainability, fostering a healthier future for all.

For more information about WuXi AppTec, visit www.wuxiapptec.com.